INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo Cortaject 100 mg (powder for injection)
Cortaject 500 mg (powder for injection)

For full prescribing information refer to the package insert approved by the medicines regulatory authority. This document has not yet been made available to us.

SCHEDULING STATUS:
S4

PROPRIETARY NAME
(and dosage form):

Cortaject 100 mg (powder for injection)
Cortaject 500 mg (powder for injection)

COMPOSITION:
Cortaject 100 mg: Each vial contains: hydrocortisone sodium succinate equivalent to
hydrocortisone 100,0 mg
Cortaject 500 mg: Each vial contains: hydrocortisone sodium succinate equivalent to hydrocortisone 500,0 mg

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
Cortaject 100 mg: 41/21.5/0016
Cortaject 500 mg: 41/21.5/0017

APPLICANT:
Strides SA Pharmaceuticals (Pty) Ltd.
Co. Reg. No. 29/13.4.2/0243.
Ground Floor, 6 De Veer Lane, Arcadia, Pretoria, South Africa, 0007.

Marketed by Aspen Pharmacare. Building 12, Healthcare Park, Woodlands Drive, Woodmead, 2191.

AVAILABILITY:
Please check with Aspen Pharmacare

DATE OF REGISTRATION:
November 2009

SOURCE:
MCC REGISTRAR OF MEDICINES
12.49 Notification of Registration Oct09v1.doc        Nov 2009

Date posted: October 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014